{"DataElement":{"publicId":"8046440","version":"1","preferredName":"Alpha Thalassemia Genotype Type","preferredDefinition":"A description of the alpha thalassemia genotype.","longName":"8044907v1.0:3298694v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"8044907","version":"1","preferredName":"Alpha Thalassemia Genotype","preferredDefinition":"A genetic hematologic disorder characterized by partial or complete absence of the alpha globin chains of the heme molecule._The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.","longName":"8044905v1.0:2224065v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"8044905","version":"1","preferredName":"Alpha Thalassemia","preferredDefinition":"A genetic hematologic disorder characterized by partial or complete absence of the alpha globin chains of the heme molecule.","longName":"C34368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha Thalassemia","conceptCode":"C34368","definition":"A genetic hematologic disorder characterized by partial or complete absence of the alpha globin chains of the heme molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83E4EF3-EBB0-031B-E053-4EBD850ADC2B","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224065","version":"1","preferredName":"Genotype","preferredDefinition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.","longName":"C16631","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genotype","conceptCode":"C16631","definition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F10ED-AE9E-51FA-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83E4EF3-EBBE-031B-E053-4EBD850ADC2B","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-17","modifiedBy":"KUMMEROA","dateModified":"2022-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3298694","version":"1","preferredName":"Genotype Type","preferredDefinition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype._Type; a subdivision of a particular kind of thing.","longName":"3298694v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hb SC","valueDescription":"Hemoglobin SC Disease","ValueMeaning":{"publicId":"3298696","version":"1","preferredName":"Hemoglobin SC Disease","longName":"3298696","preferredDefinition":"One of the sickle cell disorders characterized by the presence of both hemoglobin S and hemoglobin C. It is similar to, but less severe than sickle cell anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell-Hemoglobin C Disease","conceptCode":"C34676","definition":"A hemoglobinopathy that is considered a hybrid of sickle cell disease and hemoglobin C disease. Patients present with the symptoms of sickle cell disease but the latter are less frequent and severe compared to sickle cell disease.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B09A8A1E-AE6D-F5AB-E040-BB89AD4305DF","latestVersionIndicator":"Yes","beginDate":"2011-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B09A8A1E-AE86-F5AB-E040-BB89AD4305DF","beginDate":"2011-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-31","modifiedBy":"ONEDATA","dateModified":"2011-10-31","deletedIndicator":"No"},{"value":"Hb S beta plus thalassemia","valueDescription":"Sickle Beta Plus Thalassemia","ValueMeaning":{"publicId":"3301974","version":"1","preferredName":"Sickle Beta Plus Thalassemia","longName":"3301974","preferredDefinition":"A mild form of sickle cell thalassemia characterized by the presence of hemoglobin S and a small amount of hemoglobin A in the red blood cells. It is characterized by the presence of small red blood cells and mild anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Beta Plus Thalassemia","conceptCode":"C98837","definition":"A mild form of sickle cell thalassemia characterized by the presence of hemoglobin S and a small amount of hemoglobin A in the red blood cells. It is characterized by the presence of small red blood cells and mild anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DF96-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B128A231-DFAF-22B8-E040-BB89AD436DCB","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"ONEDATA","dateModified":"2011-11-07","deletedIndicator":"No"},{"value":"Hb S beta 0 thalassemia","valueDescription":"Sickle Beta 0 Thalassemia","ValueMeaning":{"publicId":"3301975","version":"1","preferredName":"Sickle Beta 0 Thalassemia","longName":"3301975","preferredDefinition":"A form of sickle cell thalassemia characterized by the absence of hemoglobin A. Patients usually have severe anemia identical to that seen in sickle cell disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Beta 0 Thalassemia","conceptCode":"C98835","definition":"A form of sickle cell thalassemia characterized by the absence of hemoglobin A. Patients usually have severe anemia identical to that seen in sickle cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFBB-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B128A231-DFD4-22B8-E040-BB89AD436DCB","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"ONEDATA","dateModified":"2011-11-07","deletedIndicator":"No"},{"value":"Hb SS","valueDescription":"Sickle Cell Disease","ValueMeaning":{"publicId":"3301976","version":"1","preferredName":"Sickle Cell Disease","longName":"3301976","preferredDefinition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell Disease","conceptCode":"C34383","definition":"A blood disorder characterized by the appearance of sickle-shaped red blood cells and anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B128A231-DFDE-22B8-E040-BB89AD436DCB","latestVersionIndicator":"Yes","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B128A231-DFF7-22B8-E040-BB89AD436DCB","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-11-07","modifiedBy":"ONEDATA","dateModified":"2011-11-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3241404","version":"1","preferredName":"Other","longName":"3241404","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A5D-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B49ED4DE-0D43-503E-E040-BB89AD436088","beginDate":"2011-11-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-21","modifiedBy":"ONEDATA","dateModified":"2011-12-21","deletedIndicator":"No"},{"value":"Hb S delta beta 0 thalassemia","valueDescription":"Delta-Beta Thalassemia","ValueMeaning":{"publicId":"7332469","version":"1","preferredName":"Delta-Beta Thalassemia","longName":"7332469","preferredDefinition":"A form of beta thalassemia characterized by decreased or absent synthesis of both the delta- and beta-globin chains, which leads to a compensatory increase in fetal gamma-chain synthesis. This disorder results in a microcytic anemia that is clinically mild.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Delta-Beta Thalassemia","conceptCode":"C172823","definition":"A form of beta thalassemia characterized by decreased or absent synthesis of both the delta- and beta-globin chains, which leads to a compensatory increase in fetal gamma-chain synthesis. This disorder results in a microcytic anemia that is clinically mild.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A837D118-553B-2DB1-E053-4EBD850ACB60","latestVersionIndicator":"Yes","beginDate":"2020-06-16","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-16","modifiedBy":"ONEDATA","dateModified":"2020-06-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A837D118-5554-2DB1-E053-4EBD850ACB60","beginDate":"2020-06-16","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-16","modifiedBy":"ONEDATA","dateModified":"2020-06-16","deletedIndicator":"No"},{"value":"Hb SD","valueDescription":"Sickle Cell-Hemoglobin D Disease","ValueMeaning":{"publicId":"7331882","version":"1","preferredName":"Sickle Cell-Hemoglobin D Disease","longName":"7331882","preferredDefinition":"A variant of sickle cell disease due to heterozygosity for hemoglobin S and hemoglobin D mutations. Patients present with the symptoms of sickle cell disease but the symptoms are less frequent and severe compared to patients with hemoglobin SS disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sickle Cell-Hemoglobin D Disease","conceptCode":"C155310","definition":"A variant of sickle cell disease due to heterozygosity for hemoglobin S and hemoglobin D mutations. Patients present with the symptoms of sickle cell disease but the symptoms are less frequent and severe compared to patients with hemoglobin SS disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8226024-A472-2F99-E053-4EBD850A8C5C","latestVersionIndicator":"Yes","beginDate":"2020-06-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8226024-A48B-2F99-E053-4EBD850A8C5C","beginDate":"2020-06-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"Hb SO Arab","valueDescription":"Hemoglobin S/O-Arab Heterozygote","ValueMeaning":{"publicId":"6601598","version":"1","preferredName":"Hemoglobin S/O-Arab Heterozygote","longName":"6601598","preferredDefinition":"A laboratory finding indicating that the subject expresses abnormal hemoglobin containing 2 variant forms of the hemoglobin subunit beta protein (HBB). One HBB protein variant has the amino acid substitution glutamic acid to valine at residue 6, which is associated with the formation of hemoglobin S (HbS), while the other variant has a glutamic acid to lysine substitution at residue 121, which is associated with the formation of hemoglobin O-Arab (HbO(Arab)). Subjects expressing this compound heterozygous HBB genotype may have severe sickling hemoglobinopathy with clinical manifestations similar to those of homozygous sickle cell anemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin S/O-Arab Heterozygote","conceptCode":"C156899","definition":"A laboratory finding indicating that the subject expresses abnormal hemoglobin containing 2 variant forms of the hemoglobin subunit beta protein (HBB). One HBB protein variant has the amino acid substitution glutamic acid to valine at residue 6, which is associated with the formation of hemoglobin S (HbS), while the other variant has a glutamic acid to lysine substitution at residue 121, which is associated with the formation of hemoglobin O-Arab (HbO(Arab)). Subjects expressing this compound heterozygous HBB genotype may have severe sickling hemoglobinopathy with clinical manifestations similar to those of homozygous sickle cell anemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7E90D9BE-D236-76E9-E053-F662850A2279","latestVersionIndicator":"Yes","beginDate":"2019-01-03","endDate":null,"createdBy":"COLBERTM","dateCreated":"2019-01-03","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8226024-A49F-2F99-E053-4EBD850A8C5C","beginDate":"2020-06-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-15","modifiedBy":"ONEDATA","dateModified":"2020-06-15","deletedIndicator":"No"},{"value":"BE / B0","valueDescription":"Hemoglobin Beta Heterozygous Hemoglobin E Plus Null Genotype","ValueMeaning":{"publicId":"8042285","version":"1","preferredName":"Hemoglobin Beta Heterozygous Hemoglobin E Plus Null Genotype","longName":"8042285","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has a hemoglobin beta gene (HBB) with a mutation that produces a hemoglobin subunit beta variant, the hemoglobin beta E variant, where the glutamic acid residue at position 27 has been replaced by lysine (BE) and the other copy has HBB loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia intermedia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Heterozygous Hemoglobin E Plus Null Genotype","conceptCode":"C185532","definition":"A genetic finding indicating that one copy of chromosome 16 has a hemoglobin beta gene (HBB) with a mutation that produces a hemoglobin subunit beta variant, the hemoglobin beta E variant, where the glutamic acid residue at position 27 has been replaced by lysine (BE) and the other copy has HBB loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia intermedia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BD9A-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BDB3-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"BE / B+","valueDescription":"Hemoglobin Beta Heterozygous Hemoglobin E Plus Insufficiency Genotype","ValueMeaning":{"publicId":"8042286","version":"1","preferredName":"Hemoglobin Beta Heterozygous Hemoglobin E Plus Insufficiency Genotype","longName":"8042286","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has a hemoglobin beta gene (HBB) with mutations that lead to hemoglobin subunit beta insufficiency (B+) and the other copy has an HBB mutation that produces a hemoglobin subunit beta variant, the hemoglobin beta E variant, where the glutamic acid residue at position 27 has been replaced by lysine (BE). This genotype is associated with beta thalassemia intermedia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Heterozygous Hemoglobin E Plus Insufficiency Genotype","conceptCode":"C185531","definition":"A genetic finding indicating that one copy of chromosome 16 has a hemoglobin beta gene (HBB) with mutations that lead to hemoglobin subunit beta insufficiency (B+) and the other copy has an HBB mutation that produces a hemoglobin subunit beta variant, the hemoglobin beta E variant, where the glutamic acid residue at position 27 has been replaced by lysine (BE). This genotype is associated with beta thalassemia intermedia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BDBF-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BDD8-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"B+ / B0","valueDescription":"Hemoglobin Beta Heterozygous Insufficiency Plus Null Genotype","ValueMeaning":{"publicId":"8042287","version":"1","preferredName":"Hemoglobin Beta Heterozygous Insufficiency Plus Null Genotype","longName":"8042287","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has a hemoglobin beta gene (HBB) with mutations that lead to hemoglobin subunit beta insufficiency (B+) and the other copy has HBB loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia intermedia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Heterozygous Insufficiency Plus Null Genotype","conceptCode":"C185529","definition":"A genetic finding indicating that one copy of chromosome 16 has a hemoglobin beta gene (HBB) with mutations that lead to hemoglobin subunit beta insufficiency (B+) and the other copy has HBB loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia intermedia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BDE4-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BDFD-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"B+ / B+","valueDescription":"Hemoglobin Beta Homozygous Insufficient Genotype","ValueMeaning":{"publicId":"8042288","version":"1","preferredName":"Hemoglobin Beta Homozygous Insufficient Genotype","longName":"8042288","preferredDefinition":"A genetic finding indicating that both copies of chromosome 16 each have a copy of the hemoglobin beta gene (HBB) with mutations that lead to hemoglobin subunit beta insufficiency (B+). This genotype is associated with beta thalassemia intermedia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Homozygous Insufficient Genotype","conceptCode":"C185525","definition":"A genetic finding indicating that both copies of chromosome 16 each have a copy of the hemoglobin beta gene (HBB) with mutations that lead to hemoglobin subunit beta insufficiency (B+). This genotype is associated with beta thalassemia intermedia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BE09-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BE22-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"B / B","valueDescription":"Hemoglobin Beta Normal Genotype","ValueMeaning":{"publicId":"8042289","version":"1","preferredName":"Hemoglobin Beta Normal Genotype","longName":"8042289","preferredDefinition":"A genetic finding indicating that both copies of chromosome 16 each have one functional copy of the hemoglobin beta (HBB) gene. This genotype is characterized by normal beta globin production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Normal Genotype","conceptCode":"C185524","definition":"A genetic finding indicating that both copies of chromosome 16 each have one functional copy of the hemoglobin beta (HBB) gene. This genotype is characterized by normal beta globin production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BE2E-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BE47-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BE51-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"- - / - -","valueDescription":"Hemoglobin Alpha Homozygous Null Genotype","ValueMeaning":{"publicId":"8042290","version":"1","preferredName":"Hemoglobin Alpha Homozygous Null Genotype","longName":"8042290","preferredDefinition":"A genetic finding indicating that neither copy of chromosome 16 has any functional copies of the hemoglobin alpha (HBA) genes. This genotype is associated with hemoglobin Barts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha Homozygous Null Genotype","conceptCode":"C185522","definition":"A genetic finding indicating that neither copy of chromosome 16 has any functional copies of the hemoglobin alpha (HBA) genes. This genotype is associated with hemoglobin Barts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BE5D-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BE76-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"- - / aCSa","valueDescription":"Hemoglobin Alpha cis-Deletion with Constant Spring Genotype","ValueMeaning":{"publicId":"8042291","version":"1","preferredName":"Hemoglobin Alpha cis-Deletion with Constant Spring Genotype","longName":"8042291","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has one functional copy of a hemoglobin alpha (HBA) gene and one copy that encodes an HBA stop loss mutation called hemoglobin Constant Spring (CS), while the other copy of chromosome 16 has no functional HBA genes. This genotype is associated with a severe form of hemoglobin H disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha cis-Deletion with Constant Spring Genotype","conceptCode":"C185520","definition":"A genetic finding indicating that one copy of chromosome 16 has one functional copy of a hemoglobin alpha (HBA) gene and one copy that encodes an HBA stop loss mutation called hemoglobin Constant Spring (CS), while the other copy of chromosome 16 has no functional HBA genes. This genotype is associated with a severe form of hemoglobin H disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BE82-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BE9B-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"- - / a-","valueDescription":"Hemoglobin Alpha Three Copies Deleted Genotype","ValueMeaning":{"publicId":"8042292","version":"1","preferredName":"Hemoglobin Alpha Three Copies Deleted Genotype","longName":"8042292","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has only one functional copy of a hemoglobin alpha (HBA) gene and the other copy of has no functional HBA genes. This genotype is associated with hemoglobin H disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha Three Copies Deleted Genotype","conceptCode":"C185517","definition":"A genetic finding indicating that one copy of chromosome 16 has only one functional copy of a hemoglobin alpha (HBA) gene and the other copy of has no functional HBA genes. This genotype is associated with hemoglobin H disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BEA7-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BEC0-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"a- / a-","valueDescription":"Hemoglobin Alpha trans-Deletion Genotype","ValueMeaning":{"publicId":"8042293","version":"1","preferredName":"Hemoglobin Alpha trans-Deletion Genotype","longName":"8042293","preferredDefinition":"A genetic finding indicating that both copies of chromosome 16 each have only one functional hemoglobin alpha (HBA) gene. This genotype is associated with the alpha thalassemia trait.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha trans-Deletion Genotype","conceptCode":"C185513","definition":"A genetic finding indicating that both copies of chromosome 16 each have only one functional hemoglobin alpha (HBA) gene. This genotype is associated with the alpha thalassemia trait.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BECC-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BEE5-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"- - / aa","valueDescription":"Hemoglobin Alpha cis-Deletion Genotype","ValueMeaning":{"publicId":"8042294","version":"1","preferredName":"Hemoglobin Alpha cis-Deletion Genotype","longName":"8042294","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has two functional copies of the hemoglobin alpha (HBA) genes and the other copy of has no functional HBA genes. This genotype is associated with the alpha thalassemia trait.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha cis-Deletion Genotype","conceptCode":"C185512","definition":"A genetic finding indicating that one copy of chromosome 16 has two functional copies of the hemoglobin alpha (HBA) genes and the other copy of has no functional HBA genes. This genotype is associated with the alpha thalassemia trait.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BEF1-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BF0A-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"aa / a-","valueDescription":"Hemoglobin Alpha One Copy Deleted Genotype","ValueMeaning":{"publicId":"8042295","version":"1","preferredName":"Hemoglobin Alpha One Copy Deleted Genotype","longName":"8042295","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has two functional copies of the hemoglobin alpha (HBA) genes and the other copy of has only one functional HBA gene. This genotype is associated with the alpha thalassemia silent trait.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha One Copy Deleted Genotype","conceptCode":"C185504","definition":"A genetic finding indicating that one copy of chromosome 16 has two functional copies of the hemoglobin alpha (HBA) genes and the other copy of has only one functional HBA gene. This genotype is associated with the alpha thalassemia silent trait.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BF16-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BF2F-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"aa / aa","valueDescription":"Hemoglobin Alpha Normal Genotype","ValueMeaning":{"publicId":"8042296","version":"1","preferredName":"Hemoglobin Alpha Normal Genotype","longName":"8042296","preferredDefinition":"A genetic finding indicating that both copies of chromosome 16 each has two functional copies of the hemoglobin alpha (HBA) genes, which includes 2 maternal alpha genes and 2 paternal alpha genes. This genotype is characterized by normal alpha globin production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Alpha Normal Genotype","conceptCode":"C185503","definition":"A genetic finding indicating that both copies of chromosome 16 each has two functional copies of the hemoglobin alpha (HBA) genes, which includes 2 maternal alpha genes and 2 paternal alpha genes. This genotype is characterized by normal alpha globin production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BF3B-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0916-BF54-62EE-E053-4EBD850A1DFC","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"B / B0, B / B+","valueDescription":"Hemoglobin Beta Heterozygous Null Genotype Hemoglobin Beta Heterozygous Insufficiency Genotype","ValueMeaning":{"publicId":"8049069","version":"1","preferredName":"Hemoglobin Beta Heterozygous Null Genotype Hemoglobin Beta Heterozygous Insufficiency Genotype","longName":"8049069","preferredDefinition":"A genetic finding indicating that one copy of chromosome 16 has a functional copy (B) of the hemoglobin beta gene (HBB) and the other copy has HBB loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia minor.: A genetic finding indicating that one copy of chromosome 16 has a functional copy (B) of the hemoglobin beta gene (HBB) and the other copy has HBB mutations that lead to hemoglobin subunit beta insufficiency (B+). This genotype is associated with beta thalassemia minor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Heterozygous Null Genotype","conceptCode":"C185582","definition":"A genetic finding indicating that one copy of chromosome 16 has a functional copy (B) of the hemoglobin beta gene (HBB) and the other copy has HBB loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia minor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemoglobin Beta Heterozygous Insufficiency Genotype","conceptCode":"C185581","definition":"A genetic finding indicating that one copy of chromosome 16 has a functional copy (B) of the hemoglobin beta gene (HBB) and the other copy has HBB mutations that lead to hemoglobin subunit beta insufficiency (B+). This genotype is associated with beta thalassemia minor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D84F1BB6-DB17-6207-E053-4EBD850ACFFC","latestVersionIndicator":"Yes","beginDate":"2022-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-18","modifiedBy":"ONEDATA","dateModified":"2022-02-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D84F1BB6-DB30-6207-E053-4EBD850ACFFC","beginDate":"2022-02-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-18","modifiedBy":"ONEDATA","dateModified":"2022-02-18","deletedIndicator":"No"},{"value":"B0 / B0","valueDescription":"Hemoglobin Beta Homozygous Null Genotype","ValueMeaning":{"publicId":"8042284","version":"1","preferredName":"Hemoglobin Beta Homozygous Null Genotype","longName":"8042284","preferredDefinition":"A genetic finding indicating that both copies of chromosome 16 each have a copy of the hemoglobin beta gene (HBB) with loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia major.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobin Beta Homozygous Null Genotype","conceptCode":"C185533","definition":"A genetic finding indicating that both copies of chromosome 16 each have a copy of the hemoglobin beta gene (HBB) with loss of function or gene deletion mutations (B0). This genotype is associated with beta thalassemia major.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83D0916-BD75-62EE-E053-4EBD850A1DFC","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83D0CDB-8535-7A86-E053-4EBD850A947C","beginDate":"2022-02-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3298693","version":"1","preferredName":"Genotype Type","preferredDefinition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.:Type; a subdivision of a particular kind of thing.","longName":"C16631:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genotype","conceptCode":"C16631","definition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B09A8A1E-AE43-F5AB-E040-BB89AD4305DF","latestVersionIndicator":"Yes","beginDate":"2011-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-31","modifiedBy":"ONEDATA","dateModified":"2011-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B09A8A1E-AE54-F5AB-E040-BB89AD4305DF","latestVersionIndicator":"Yes","beginDate":"2011-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-10-31","modifiedBy":"KUMMEROA","dateModified":"2022-02-18","changeDescription":"Released 07/30/2020 KMM; 12/20/11: changed conceptural domain \"Gene\".wz. Added PVs for 2030r3. 06/15/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the alpha thalassemia","type":"Preferred Question Text","description":"What is the alpha thalassemia genotype?","url":null,"context":"NHLBI"},{"name":"What is the alpha-globin genotype?","type":"Application Standard Question Text","description":"What is the alpha-globin genotype?","url":null,"context":"NHLBI"},{"name":"What is the recipient's alpha-globin genotype?","type":"Alternate Question Text","description":"What is the recipient's alpha-globin genotype?","url":null,"context":"NHLBI"},{"name":"What is the alpha-globin genotype?","type":"Alternate Question Text","description":"What is the alpha-globin genotype?","url":null,"context":"NHLBI"},{"name":"What is the donor's alpha-globin genotype?","type":"Alternate Question Text","description":"What is the donor's alpha-globin genotype?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83E4EF3-ECA2-031B-E053-4EBD850ADC2B","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-17","modifiedBy":"KUMMEROA","dateModified":"2022-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}